Replies to post #347000 on NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

Split history is interesting, but not indicative of current value or future value. It is a snap shot of what has happened in the past. Current value and future can best be determined by looking at the following:

1. How probable is it that the DCVax-L Phase III trial will be successful?
2. If the DCVax-L Phase III trial is sucessful, and meets it primary endpoints, and it also meet most of, if not all secondary endpoints, what is its addressable market size & potential revenue potential in the US, UK, Germany & Canada?
3. Will the DCVax vaccine platform (L & Direct) prove to be effective against most other solid tumor cancers, both operable & inoperable.
4. What is the addressable market potential & revenue potential in the rest of the world (ROW)?
5. How may common shares are outstanding on a fully-diluted basis?
6. Financial markets are forward-looking, what will be the estimated price per share in 5 years, 7 years, 10 years, etc.

[Mortimerduke]

And your historical information is intended to encourage/influence NWBO stock buy or sell decisions? Is it your suggestion that those of us long in NWBO must have been uninformed when buying NWBO? Thank you for your concern.